Core Insights - Baird Medical Investment Holdings Ltd. has appointed Mark Saxton as the new CEO of its U.S. subsidiary, aiming to enhance its market presence in the U.S. [1] - Saxton brings over 25 years of experience in the medical device industry, particularly in intravascular RF ablation technologies, and has a history of driving significant revenue growth and successful exits for medtech companies [1] - The company is focused on advancing its Microwave Ablation technology, which offers advantages in minimally invasive care, and aims to expand access for patients while creating shareholder value [1] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, with a commitment to research and development of surgical robotic systems and innovative surgical instruments [1] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics in the U.S., including Mayo Clinic and UCSF Medical Center [1] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [1]